Tecan Group (TECN) Aktienübersicht
Die Tecan Group AG bietet Laborinstrumente und Lösungen in den Bereichen Biopharmazie, Forensik und klinische Diagnostik in Europa, Nordamerika, Asien und international an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 4/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 3/6 |
TECN Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Tecan Group AG Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | CHF 191.20 |
| 52-Wochen-Hoch | CHF 202.00 |
| 52-Wochen-Tief | CHF 110.60 |
| Beta | 1.08 |
| 1 Monat Veränderung | 7.00% |
| 3 Monate Veränderung | 29.19% |
| 1 Jahr Veränderung | 11.36% |
| 3 Jahre Veränderung | -44.64% |
| 5 Jahre Veränderung | -66.49% |
| Veränderung seit IPO | 307.68% |
Aktuelle Nachrichten und Updates
Narrative-Update • Aug 18
TECN: Margin Execution Concerns Will Constrain Upside Despite Raised Expectations
Analysts have raised the fair value estimate for Tecan Group from CHF 142.0 to CHF 160.0, reflecting updated assumptions on revenue growth, profit margins and valuation in the context of recent price target increases from major banks. Analyst Commentary Recent research on Tecan Group shows a mix of optimism and caution.
Narrative-Update • Aug 04
TECN: Margin Upside And India Expansion Will Support Future Earnings Re Rating
Analysts have raised the Tecan Group fair value estimate from CHF 205.00 to CHF 220.00, reflecting updated price targets on the stock and an assessment that its margin potential may not be fully reflected in current valuations. Analyst Commentary Recent research on Tecan Group highlights a more constructive tone from several bullish analysts.
Narrative-Update • Jul 20
TECN: Margin Execution And India Expansion Will Shape Fairly Valued Outlook
The analyst price target for Tecan Group has been raised by CHF 8.50 to CHF 175.48, with analysts pointing to updated fair value assumptions, a slightly lower discount rate, and an ongoing focus on margin potential as reflected in recent CHF 142 to CHF 208 Street targets. Analyst Commentary Street research on Tecan Group has become more active, with several firms updating price targets and ratings.Recent updates
Narrative-Update • Aug 18
TECN: Margin Execution Concerns Will Constrain Upside Despite Raised Expectations
Analysts have raised the fair value estimate for Tecan Group from CHF 142.0 to CHF 160.0, reflecting updated assumptions on revenue growth, profit margins and valuation in the context of recent price target increases from major banks. Analyst Commentary Recent research on Tecan Group shows a mix of optimism and caution.Narrative-Update • Aug 04
TECN: Margin Upside And India Expansion Will Support Future Earnings Re Rating
Analysts have raised the Tecan Group fair value estimate from CHF 205.00 to CHF 220.00, reflecting updated price targets on the stock and an assessment that its margin potential may not be fully reflected in current valuations. Analyst Commentary Recent research on Tecan Group highlights a more constructive tone from several bullish analysts.Narrative-Update • Jul 20
TECN: Margin Execution And India Expansion Will Shape Fairly Valued Outlook
The analyst price target for Tecan Group has been raised by CHF 8.50 to CHF 175.48, with analysts pointing to updated fair value assumptions, a slightly lower discount rate, and an ongoing focus on margin potential as reflected in recent CHF 142 to CHF 208 Street targets. Analyst Commentary Street research on Tecan Group has become more active, with several firms updating price targets and ratings.Narrative-Update • Jul 06
TECN: Margin Execution Risks Will Limit Future Upside Potential
Tecan Group's updated fair value estimate has moved from CHF 136.0 to CHF 142.0, reflecting analysts' higher price targets and expectations for slightly improved revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research on Tecan Group shows a mix of optimism and caution, with higher price targets from some firms set against more restrained views from others.Narrative-Update • Jun 14
TECN: Reset CHF 205 Goal Will Support Future Earnings Re Rating
Analysts have reduced their price target for Tecan Group from CHF 335.08 to CHF 205.00, citing updated assumptions for revenue growth, profit margins and future P/E multiples, along with recent Street research cuts from CHF 10 and CHF 1. Analyst Commentary Recent Street research has focused on recalibrating Tecan Group’s valuation framework, with price targets adjusted to reflect updated views on revenue growth, margins and P/E multiples.Narrative-Update • May 31
TECN: Reduced P/E Expectations Will Limit Perceived Upside Potential
Analysts have trimmed their price targets on Tecan Group by CHF 1 to CHF 10 in recent updates. This reflects revised assumptions around discount rates, profit margins and future P/E expectations.Narrative-Update • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.Narrative-Update • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.Narrative-Update • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Narrative-Update • Mar 20
TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings
The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.Narrative-Update • Mar 05
TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations
Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.Narrative-Update • Feb 19
TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E
Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Narrative-Update • Feb 05
TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential
Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.Narrative-Update • Jan 22
TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside
Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.Narrative-Update • Jan 08
TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings
Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.Analyseartikel • Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrative-Update • Dec 14
TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential
Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.Narrative-Update • Nov 30
TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements
Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.Narrative-Update • Nov 16
TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026
Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.Analyseartikel • Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...Narrative-Update • Nov 01
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.Analyseartikel • Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?
Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...Narrative-Update • Oct 18
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.Narrative-Update • Oct 04
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.Narrative-Update • Sep 05
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.Analyseartikel • Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)
SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...Analyseartikel • Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price
Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...Analyseartikel • Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Analyseartikel • May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?
While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...Analyseartikel • Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?
Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...Analyseartikel • Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...Analyseartikel • Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely
Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...Analyseartikel • Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Neues Narrative • Mar 16
Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production
Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.Analyseartikel • Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Analyseartikel • Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...Analyseartikel • Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Analyseartikel • Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyseartikel • Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...Aktionärsrenditen
| TECN | CH Life Sciences | CH Markt | |
|---|---|---|---|
| 7D | 4.8% | -1.1% | -1.6% |
| 1Y | 11.4% | 1.6% | 14.7% |
Rendite im Vergleich zur Industrie: TECN übertraf die Branche Swiss Life Sciences , die im vergangenen Jahr eine Rendite von 1.6 erzielte.
Rendite vs. Markt: TECN hinter dem Markt Swiss zurück, der im vergangenen Jahr eine Rendite von 14.7 erzielte.
Preisvolatilität
| TECN volatility | |
|---|---|
| TECN Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 5.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 2.1% |
Stabiler Aktienkurs: Der Aktienkurs von TECN war in den letzten 3 Monaten im Vergleich zum Swiss -Markt volatil.
Volatilität im Zeitverlauf: TECNDie wöchentliche Volatilität (6%) war im vergangenen Jahr stabil, liegt aber immer noch höher als bei 75 % der Swiss Aktien.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1980 | 3,000 | Monica Manotas | www.tecan.com |
Die Tecan Group AG bietet Laborinstrumente und Lösungen in den Bereichen Biopharmazie, Forensik und klinische Diagnostik in Europa, Nordamerika, Asien und international an. Sie ist in zwei Segmenten tätig: Life Sciences Business und Partnering Business. Das Unternehmen bietet Liquid Handling und Automation, Mikroplatten-Reader und Washers, Software, Verbrauchsmaterialien, Sequenzierungsreagenzien, Immunoassays und Antikörper sowie Tecan Labwerx, eine End-to-End-Automatisierungslösung.
Tecan Group AG's Grundlagenzusammenfassung
| TECN grundlegende Statistiken | |
|---|---|
| Marktanteil | CHF 2.36b |
| Gewinn(TTM) | -CHF 116.30m |
| Umsatz(TTM) | CHF 870.53m |
2.7x
Kurs-Umsatz-Verhältnis-20.3x
Kurs-Gewinn-Verhältnis Ist TECN zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| TECN Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | CHF 870.53m |
| Kosten der Einnahmen | CHF 574.03m |
| Bruttogewinn | CHF 296.50m |
| Sonstige Ausgaben | CHF 412.81m |
| Gewinn | -CHF 116.30m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
Nov 05, 2026
| Gewinn per Aktie (EPS) | -9.44 |
| Bruttomarge | 34.06% |
| Nettogewinnspanne | -13.36% |
| Schulden/Eigenkapital-Verhältnis | 13.6% |
Wie hat sich TECN auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.6%
Aktuelle Dividendenrendite-32%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/19 02:26 |
| Aktienkurs zum Tagesende | 2026/08/19 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Tecan Group AG wird von 16 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Harry Gillis | Berenberg |
| Delphine Le Louet | Bernstein |
| Susannah Ludwig | Bernstein |